Description

Citra 100 mg (Tramadol Hydrochloride)

Citra 100 mg is an oral, centrally acting analgesic formulation containing tramadol hydrochloride. It delivers dual-mechanism pain relief by binding as a weak $\mu$-opioid receptor agonist while simultaneously inhibiting the neuronal reuptake of norepinephrine and serotonin. This combined action modifies both ascending pain signals and descending inhibitory pathways within the central nervous system.

Product Overview

Primary Indications

Citra 100 mg is prescribed under qualified clinical guidance for:

• Moderate to Moderately Severe Pain: Management of acute pain episodes where non-opioid analgesics (such as NSAIDs or acetaminophen) are insufficient or contraindicated.

• Post-Operative or Post-Traumatic Pain: Short-term relief following surgical procedures, musculoskeletal injuries, or acute orthopedic trauma.

• Chronic Pain Management: Regulated treatment of chronic conditions (such as severe osteoarthritis or neuropathic pain) when alternative therapeutic options have failed to provide adequate relief.

Key Information & Precautions

• Dosage & Administration: Must be taken strictly as prescribed by a licensed healthcare provider. Do not exceed the maximum recommended daily ceiling (typically 400 mg/day for adults with normal renal and hepatic function) to minimize severe toxicity risks.

• Seizure Risk: Tramadol lowers the seizure threshold. The risk of convulsions increases significantly at doses above the recommended range or when co-administered with SSRIs, SNRIs, tricyclic antidepressants, antipsychotics, or other epileptogenic agents.

• Serotonin Syndrome: Co-administration with serotonergic medications (e.g., triptans, linezolid, St. John’s Wort) may precipitate life-threatening serotonin toxicity. Symptoms include agitation, hyperthermia, tremor, hyperreflexia, and diaphoresis.

• Dependence, Abuse, and Tolerance: Although tramadol exhibits a lower affinity for opioid receptors compared to classic opioids like morphine, it carries a definitive risk of physical dependence, psychological addiction, and misuse.

• Discontinuation: Abrupt cessation after extended use can trigger withdrawal symptoms, including classic opioid withdrawal signs alongside atypical serotonergic rebound effects (e.g., hallucinations, severe anxiety, paresthesia). Tapering is required.

• CNS & Respiratory Depression: Can induce somnolence, dizziness, and compromised motor function. Patients should not drive or operate heavy machinery. Concomitant use with alcohol, benzodiazepines, or other central nervous system depressants substantially increases the risk of severe respiratory depression, profound sedation, coma, and fatal overdose.